The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Y NikiJapanese Society of Chemotherapy

Abstract

The Japanese Society of Chemotherapy (JSC) conducted the first nationwide surveillance of bacterial respiratory pathogens during the period from January to August 2006. With the cooperation of 32 medical institutions throughout Japan, a total of 924 strains belonging to seven clinically relevant bacterial species were collected from adult patients with well-diagnosed respiratory tract infections (RTIs). Antimicrobial susceptibility testing of the 887 evaluable strains (205 Staphylococcus aureus, 200 Streptococcus pneumoniae, 9 Streptococcus pyogenes, 165 Haemophilus influenzae, 91 Moraxella catarrhalis, 74 Klebsiella pneumoniae, and 143 Pseudomonas aeruginosa) to 42 antibacterial agents was conducted at the Central Laboratory of the Research Center for Anti-infective Drugs of the Kitasato Institute, according to recommendations issued by the Clinical and Laboratory Standards Institute (CLSI). The antibacterial agents employed were 25 beta-lactams, three aminoglycosides, four macrolides (including one azalide and one ketolide), one lincosamide, one tetracycline, two glycopeptides, five fluoroquinolones, and one oxazolidinone. The incidence of methicillin-resistant S. aureus (MRSA) was 63.4%, and the incidences of penicillin-inte...Continue Reading

References

Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·K HiramatsuF C Tenover
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettM J Fine
Jan 18, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R ColodnerR Kubo
Jul 11, 2006·International Journal of Antimicrobial Agents·Tetsuro Muratani, Tetsuro Matsumoto
Apr 27, 2007·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kazunari BaradaKeisuke Sunakawa
Apr 27, 2007·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideaki HanakiKeisuke Sunakawa

❮ Previous
Next ❯

Citations

Dec 24, 2010·Clinical and Vaccine Immunology : CVI·Hidehito MatsuiSatoshi Omura
Jan 31, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shigeru KohnoMasahito Nagashima
Feb 1, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hisashi ShojiYoshihito Niki
May 24, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshihiro YamamotoShigeru Kohno
Feb 4, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Liang QinHiroshi Watanabe
Dec 29, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·S M SharmaJ B Hudson
Jul 30, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Hideaki HanakiYoshihito Niki
Jun 26, 2009·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Y NikiK Totsuka
Jul 22, 2014·Auris, Nasus, Larynx·Noboru YamanakaUNKNOWN Drafting Committee for Acute Rhinosinusitis Management Guideline, Japanese Rhinologic Society
Oct 22, 2008·Journal of Bacteriology·Masanori ToyofukuHiroo Uchiyama
Oct 6, 2009·Journal of Bacteriology·Takashi InaokaKozo Ochi
Apr 9, 2013·Bioscience, Biotechnology, and Biochemistry·Ryohei KobayashiTakeshi Sugai
Apr 3, 2021·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Takashi UedaHideki Kawamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.